vs

Side-by-side financial comparison of Ibotta, Inc. (IBTA) and Liquidia Corp (LQDA). Click either name above to swap in a different company.

Liquidia Corp is the larger business by last-quarter revenue ($92.0M vs $82.5M, roughly 1.1× Ibotta, Inc.). On growth, Liquidia Corp posted the faster year-over-year revenue change (3054.6% vs -2.5%). Liquidia Corp produced more free cash flow last quarter ($42.2M vs $23.3M).

Ibotta, Inc. is an American mobile technology company headquartered in Denver, Colorado. Founded in 2011, the company offers cash back rewards on various purchases through its Ibotta Performance Network and direct to consumer app. Ibotta partners with CPG brands and network publishers to provide these rewards. As of 2024, the company operates solely in the United States. The company's rewards-as-a-service offering, the Ibotta Performance Network, went live in 2022.

Liquidia Corp is a late-stage biopharmaceutical firm focused on developing and commercializing innovative inhaled therapies for respiratory and rare diseases. It uses its proprietary PRINT particle engineering tech to create optimized drug products, with core markets in North America covering pulmonary arterial hypertension and asthma indications.

IBTA vs LQDA — Head-to-Head

Bigger by revenue
LQDA
LQDA
1.1× larger
LQDA
$92.0M
$82.5M
IBTA
Growing faster (revenue YoY)
LQDA
LQDA
+3057.1% gap
LQDA
3054.6%
-2.5%
IBTA
More free cash flow
LQDA
LQDA
$18.9M more FCF
LQDA
$42.2M
$23.3M
IBTA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
IBTA
IBTA
LQDA
LQDA
Revenue
$82.5M
$92.0M
Net Profit
$14.6M
Gross Margin
76.4%
Operating Margin
10.4%
21.5%
Net Margin
15.8%
Revenue YoY
-2.5%
3054.6%
Net Profit YoY
137.9%
EPS (diluted)
$-0.43
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBTA
IBTA
LQDA
LQDA
Q1 26
$82.5M
Q4 25
$88.5M
$92.0M
Q3 25
$83.3M
$54.3M
Q2 25
$86.0M
Q1 25
$84.6M
Q4 24
$98.4M
Q3 24
$98.6M
Q2 24
$87.9M
Net Profit
IBTA
IBTA
LQDA
LQDA
Q1 26
Q4 25
$14.6M
Q3 25
$1.5M
$-3.5M
Q2 25
$2.5M
Q1 25
$555.0K
Q4 24
Q3 24
$17.2M
Q2 24
$-34.0M
Gross Margin
IBTA
IBTA
LQDA
LQDA
Q1 26
76.4%
Q4 25
78.7%
Q3 25
79.4%
Q2 25
79.2%
Q1 25
79.8%
Q4 24
84.6%
Q3 24
87.7%
Q2 24
86.0%
Operating Margin
IBTA
IBTA
LQDA
LQDA
Q1 26
10.4%
Q4 25
-1.9%
21.5%
Q3 25
2.8%
3.3%
Q2 25
1.4%
Q1 25
-3.3%
Q4 24
13.2%
Q3 24
21.0%
Q2 24
-24.6%
Net Margin
IBTA
IBTA
LQDA
LQDA
Q1 26
Q4 25
15.8%
Q3 25
1.8%
-6.5%
Q2 25
2.9%
Q1 25
0.7%
Q4 24
Q3 24
17.5%
Q2 24
-38.6%
EPS (diluted)
IBTA
IBTA
LQDA
LQDA
Q1 26
$-0.43
Q4 25
$-0.03
$0.18
Q3 25
$0.05
$-0.04
Q2 25
$0.08
Q1 25
$0.02
Q4 24
$3.04
Q3 24
$0.51
Q2 24
$-1.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBTA
IBTA
LQDA
LQDA
Cash + ST InvestmentsLiquidity on hand
$164.6M
$190.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$249.0M
$44.7M
Total Assets
$479.9M
$327.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBTA
IBTA
LQDA
LQDA
Q1 26
$164.6M
Q4 25
$186.6M
$190.7M
Q3 25
$223.3M
$157.5M
Q2 25
$250.5M
Q1 25
$297.1M
Q4 24
$349.3M
Q3 24
$341.3M
Q2 24
$317.9M
Total Debt
IBTA
IBTA
LQDA
LQDA
Q1 26
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
$0
Q3 24
$0
Q2 24
$0
Stockholders' Equity
IBTA
IBTA
LQDA
LQDA
Q1 26
$249.0M
Q4 25
$287.7M
$44.7M
Q3 25
$329.6M
$22.1M
Q2 25
$354.1M
Q1 25
$401.3M
Q4 24
$457.3M
Q3 24
$378.0M
Q2 24
$359.7M
Total Assets
IBTA
IBTA
LQDA
LQDA
Q1 26
$479.9M
Q4 25
$525.9M
$327.9M
Q3 25
$569.4M
$276.0M
Q2 25
$600.8M
Q1 25
$639.3M
Q4 24
$678.4M
Q3 24
$598.3M
Q2 24
$556.0M
Debt / Equity
IBTA
IBTA
LQDA
LQDA
Q1 26
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBTA
IBTA
LQDA
LQDA
Operating Cash FlowLast quarter
$30.4M
$44.2M
Free Cash FlowOCF − Capex
$23.3M
$42.2M
FCF MarginFCF / Revenue
28.2%
45.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
3.04×
TTM Free Cash FlowTrailing 4 quarters
$80.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBTA
IBTA
LQDA
LQDA
Q1 26
$30.4M
Q4 25
$27.8M
$44.2M
Q3 25
$21.8M
$-9.8M
Q2 25
$25.9M
Q1 25
$19.9M
Q4 24
$22.0M
Q3 24
$39.5M
Q2 24
$35.0M
Free Cash Flow
IBTA
IBTA
LQDA
LQDA
Q1 26
$23.3M
Q4 25
$20.3M
$42.2M
Q3 25
$14.5M
$-10.7M
Q2 25
$22.2M
Q1 25
$18.0M
Q4 24
$21.8M
Q3 24
$39.2M
Q2 24
$34.8M
FCF Margin
IBTA
IBTA
LQDA
LQDA
Q1 26
28.2%
Q4 25
22.9%
45.9%
Q3 25
17.4%
-19.7%
Q2 25
25.8%
Q1 25
21.2%
Q4 24
22.1%
Q3 24
39.8%
Q2 24
39.6%
Capex Intensity
IBTA
IBTA
LQDA
LQDA
Q1 26
Q4 25
8.5%
2.2%
Q3 25
8.7%
1.7%
Q2 25
4.2%
Q1 25
2.2%
Q4 24
0.2%
Q3 24
0.3%
Q2 24
0.2%
Cash Conversion
IBTA
IBTA
LQDA
LQDA
Q1 26
Q4 25
3.04×
Q3 25
14.19×
Q2 25
10.38×
Q1 25
35.78×
Q4 24
Q3 24
2.29×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBTA
IBTA

Redemption revenue$54.0M65%
Other$19.0M23%
Ad & other revenue$9.5M11%

LQDA
LQDA

Segment breakdown not available.

Related Comparisons